UPDATE
: Friday, December 13, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Seniors account for 41% of total medical expense
by Kim Eun-young
2019-11-07 15:16
8 Chinese medical schools delisted from world directory of medical schools
by Choi Gwang-seok
2019-11-07 14:07
‘Lung cancer screening was effective in numerous studies’
by Jeong Sae-im
2019-11-07 14:06
Celltrion marks robust Q3 sales
by Lee Han-soo
2019-11-07 14:03
Samsung Bioepis, Biogen to commercialize next-generation biosimilar candidates
by Lee Han-soo
2019-11-07 11:16
라인
'AI accurately diagnoses abnormalities from chest X-rays'
by Lee Han-soo
2019-11-07 08:25
‘One-third of heart attack survivors overlook risk of recurrence’
by Lee Han-soo
2019-11-06 16:34
AbbVie’s hepatitis C drug gets 8-week therapy regardless of cirrhosis
by Kim Yun-mi
2019-11-06 16:00
Crystal Genomics, Daehwa win patent for patch-form arthritis drug
by Lee Han-soo
2019-11-06 15:57
Shorter residency in internal medicine causes treatment vacuum
by Choi Gwang-seok
2019-11-06 15:56
라인
Dong-A ST's treatment of nail athlete's foot dominates local market
by Lee Han-soo
2019-11-06 14:09
SNUBH 1st local hospital to get certification from global accreditor
by Lee Han-soo
2019-11-06 14:08
Regulator to consider re-classifying choline alfoscerate as functional food
by Kim Yun-mi
2019-11-06 13:54
Neofect wins patent for wearable robot glove
by Lee Han-soo
2019-11-05 17:51
‘Extracorporeal shock wave therapy effective in treating chronic prostatitis’
by Lee Han-soo
2019-11-05 17:16
라인
Cell Return acquires Speclipse
by Lee Han-soo
2019-11-05 16:49
Daewoong to sell Merck's cardiovascular disease treatment
by Lee Han-soo
2019-11-05 15:05
Merck Korea hurries to close GM part despite union’s protest
by Kim Yun-mi
2019-11-05 15:04
Court rejects arrest warrant for 2 Kolon execs
by Jeong Sae-im
2019-11-05 13:54
Samsung BioLogics to make Ichnos Sciences’ atopic dermatitis treatment
by Lee Han-soo
2019-11-05 12:47
-
1
2
3
4
5
6
7
8
9
10
다음
-
GC, Add Pharma to co-develop synthetic drugs
Helixmith to clarify why gene therapy study had data error
Daewoong releases trial results for autoimmune disease treatment candidate
Medical kiosks installed at major subway stations to help foreigners
GC, Add Pharma to co-develop synthetic drugs
Helixmith to clarify why gene therapy study had data error
Daewoong releases trial results for autoimmune disease treatment candidate
Medical kiosks installed at major subway stations to help foreigners
여백
Most viewed
1
Aprogen, 1st Korean biotech firm to win unicorn status
2
Korea selected as 'Medical Tourism Destination of the Year'
3
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
4
ABL Bio unveils new bispecific antibody at US meet
5
AbbVie's releases new data for chronic lymphocytic leukemia treatment
6
Will partial success of Biogen’s Alzheimer’s drug lead to FDA approval?
7
Samsung execs get jail term for destroying evidence
8
Japan OKs Medipost's P2 trial of stem cell-serviced osteoarthritis treatment
9
Korean physician 1st Asian to do 1,000 robotic myomectomy surgeries
10
Samsung Bioepis to start P3 trial for Ontruzant in China
여백
Opinion
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
여백
Back to Top